1 Revolutionary Drugs - Groundbreaking GLP-1 treatments, such as Ozempic, Wegovy, and Zepbound, are leading medical advancements in weight management
Descubre ms en nuestro artculo
For instance, in August 2025, Viking Therapeutics, a US-based company specializing in metabolic and endocrine disorder treatments, announced positive top-line results from its Phase 2 VENTURE-Oral Dosing trial of VK2735, an investigational oral dual GLP-1/GIP agonist for obesity
The ADA recommends treating type 2 diabetes in the presence of MASLD also by combining a GLP-1 with pioglitazone in this setting to enhance metabolic control and further reduce hepatic steatohepatitis
doi:10.3945/ajcn.115.112185
Thiamine-reduced fatigue in quiescent inflammatory bowel disease is linked to Faecalibacterium prausnitzii abundance